Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 463

The DOI matches its Crossref record; 95 of the 95 references it cites were found in a registry or an index.

Anti-Inflammatory Drugs in the 21st Century

Rainsford, K.D.·2007·Subcellular Biochemistry

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1007/1-4020-5688-5_1

Cites

95 of 95 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

1 retracted

Show all 95 references

Research works printed but not linked: 51

  1. Bennett A, Charlier EM, McDonald AM, Simpson JS, Stamford IF. Bonedestruction by breast tumours. Prostaglandins. 1976;11:461–463. · doi:10.1016/0090-6980(76)90079-4
  2. Bennett A. Prostaglandins as factors in diseases of the alimentary tract. Adv Prostaglandin Thromboxane Res. 1976;2:547–555.
  3. Bennett A, McDonals AM, Simpson JS, Stamford IF. Breast cancer,prostaglandins, and bone metastases. Lancet. 1975;31:1218–1220. · doi:10.1016/s0140-6736(75)92197-2
  4. Bennett A, Del Tacca M. Proceedings: Prostaglandins in human colonic carcinoma. Gut. 1975;16:409.
  5. Bennett A, Effects of kinins and prostaglandins on the gut. Proc RSoc Med. 1971;64:12–13.
  6. Bernstein S. Historic reflection on steroids: Lederle and personal aspects. Steroids. 1992;57:392–402. · doi:10.1016/0039-128x(92)90083-l
  7. Bolos J. Structure-activity relationships of p38 mitogen-activated protein kinase inhibitors. Mini Rev Med Chem. 2005;5:857–868. · doi:10.2174/1389557054867048
  8. Bolla M, Zoli W. Molecular characterization of cytotoxic and resistance mechanisms induced by NCX 4040, a novel NO-NSAID, in pancreatic cancer cell lines Apoptosis. 2006;11:1321–30.
  9. Brooks PM, Buchanan WW, Rosenbloom D, Bellamy N. Clinical efficacy and responses in therapy with anti-inflammatory and anti-rheumaticdrugs. In: Anti-Inflammatory and Anti-Rheumatic Drugs, Vol III: Anti-Rheumatic Drugs, Experimental Agents, and Clinical Aspects of Drug Use, K D Rainsford, ed. Boca Raton (Fl): CRC Press, 1985, 167–203.
  10. Chiroli V, Benedini F, Ongini E, Del Soldato P. Nitric oxide-donating non-steroidal anti-inflammatory drugs: the case ofnitroderivatives of aspirin. Eur J Med Chem. 2003;38:441–446. · doi:10.1016/s0223-5234(03)00055-2
  11. Corazzi T, Leone M, Roberti R, Del Soldato P, Gresele P. Effect of nitric oxide-donating agents on human monocyte cyclooxygenase-2. Biochem Biophys Res Commun. 2003;311:897–903. · doi:10.1016/j.bbrc.2003.10.079
  12. Dargent D. Utilization of tanderil during radium therapy of cancer of the female genital apparatus. Lyon Med. 1969;221:1261–1262.
  13. De Leval X, Delarge J, Somers F, de Tullio P, Henrotin Y, Pirotte B, Dognè J-M. Recent advances in inducible cyclooxygenase(COX-2) inhibition. Curr Med Chem. 2000;7:1041–1062. · doi:10.2174/0929867003374417
  14. Diller DJ, Lin TH, Metzger A. The discovery of novel chemotypes of p38 kinase inhibitors. Curr Top Med Chem. 2005;5:953–965. · doi:10.2174/1568026054985948
  15. Elhajj II, Haydar AA, Hujairi NM, Goldsmith DJ. The role of inflammation in acute coronary syndromes: review of the literature. J Med Liban. 2004;52:96–102.
  16. Evans D, Williamson WRN. Chemistry of clinically active anti-inflammatory compounds. In: Anti-Inflammatory Compounds. New York & Basel: Marcel Dekker, 1987, 193–302.
  17. Fabbri F, Brigliadori G, Ulivi P, Tesei A, Vannini I, Rosetti M, Bravaccini S, Amadori D, Bolla M, Zoli W. Pro-apoptotic effect of a nitric oxide-donating NSAID, NCX 4040, on bladder carcinomacells. Apoptosis. 2005;10:1095–1103. · doi:10.1007/s10495-005-0619-7
  18. Gao J, Kashfi K, Rigas B. In vitro metabolism of nitricoxide-donating aspirin: the effect of positional isomerism. JPharmacol Exp Ther. 2005;312:989–997. · doi:10.1124/jpet.104.076190
  19. Goodwin JS, Bankhurst AD, Murphy SA, Selinger DS, Messner RP, Williams RC Jr. Partial reversal of the cellular immune defect in common variable immunodeficiency with indomethacin. J. CLin. Lab. Immunol. 1978;1:197–199.
  20. Goldstein DM, Alfredson T, Bertrand J, Browner MF, Clifford K, Dalrymple SA, Dunn J, Freire-Moar J, Harris S, Labadie SS, LaFargue J, Lapierre JM, Larrabee S, Li F, Papp E, McWeeney D, Ramesha C, Roberts R, Rotstein D, San Pablo B, Sjogren EB, So OY,Talamas FX, Tao W, Trejo A, Villasenor A, Welch M, Welch T, Weller P, Whiteley PE, Young K, Zipfel S. Discovery of S-[5-amino-1-(4-fluorophenyl)-1H-pyrazol-4-yl]-[3-(2,3-dihydroxypropoxy)-phenyl]methanone(RO3201195), an orally bioavailable and highly selective inhibitor of p38 MAP kinase. J Med Chem. 2006;49: 1562–1575. · doi:10.1021/jm050736c
  21. Harris RE. Epidemiology of breast cancer and nonsteroidal anti-inflammatory drugs. In: COX-2 Blockade in Cancer Prevention and Therapy. R.E. Harris, ed. Totawa, NJ: HumanaPress, 2002b, 57–68. · doi:10.1385/1-59259-302-x:57
  22. Hirschmann R. The cortisone era: aspects of its impact. Some contributions of the Merck Laboratories. Steroids.y1992;57:579–592. · doi:10.1016/0039-128x(92)90012-x
  23. Huguenin S, Fleury-Feith J, Kheuang L, Jaurand MC, Bolla M, Riffaud JP, Chopin DK, Vacherot F. Nitrosulindac (NCX 1102): a new nitric oxide-donating non-steroidal anti-inflammatory drug(NO-NSAID), inhibits proliferation and induces apoptosis in human prostatic epithelial cell lines. Prostate. 2004a;61:132–141. · doi:10.1002/pros.20081
  24. JForl J. Trial of Tandearil in prevention of cutaneous and mucosal complications in patients with otoshinolaryngeal neoplasms treatedby irradiation. Otorhinolaryngeal Audiophonol Chir Maxillofac.1976;25:175–178.
  25. Klein U, Muller-Fassbender H, Bublath H, Heinze HG. Effects of oxyphenbutazone on radiation fibrosis following irradiation for breast carcinoma. Strahlentherapie. 1972;144:421–429.
  26. Levine L, Hinkle PM, Voelkel EF, Tashjian AH Jr. Prostaglandin production by moouse fibrosarcoma cells in culture: inhibition by indomethacin and aspirin. Biochem Biophys Res Commun. 1972;47: 888–896. · doi:10.1016/0006-291x(72)90576-1
  27. Lin TH, Metzger A, Diller DJ, Desai M, Henderson I, Ahmed G, Kimble EF, Quadros E, Webb ML. Discovery and characterization of triaminotriazine aniline amides as highly selective p38 kinase inhibitors. J Pharmacol Exp Ther. 2006;318:495–502. · doi:10.1124/jpet.105.097568
  28. Lindahl F. Intestinal injuries following irradiation for carcinoma of the uterine cervix and vesical carcinoma. Acta Chir Scand. 1970;136:725–730.
  29. LiVolsi VA. Anti-metastatic effect of aspirin. Lancet. 1973;2:263. · doi:10.1016/s0140-6736(73)93169-3
  30. Metzger A, Diller DJ, Lin TH, Henderson I, Webb ML. Successful screening of large encoded combinatorial libraries leading to the discovery of novel p38 MAP kinase inhibitors. Comb Chem High Throughput Screen. 2006;9:351–358. · doi:10.2174/138620706777452384
  31. Muller-Fassbender H, Klein U, Bablath H, Heinze HG. Effect of oxyphenbutazone on radiation-induced lung diseases. Med Klin. 1973; 68:478–483.
  32. Nash P, Clegg DO. Psoriatic arthritis therapy: NSAIDs and traditional DMARDs. Ann Rheum Dis. 2005 Mar;64 Suppl 2:ii74–7. · doi:10.1136/ard.2004.030783
  33. O’Brien JR. Effects of salicylates on human platelets. Lancet. 1968; 1(4546), 779–783. · doi:10.1016/s0140-6736(68)92228-9
  34. Paulus HE. Clinical trial design for evaluating combination therapies. Br J Rheumatol. 1995;34 Suppl 2:92–95 · doi:10.1093/rheumatology/xxxiv.suppl_2.92
  35. Powles TJ, Easty DM, Easty GC, Neville AM. Tumor-induced osteolysis. N Engl J Med. 1974;291:105. · doi:10.1056/nejm197407112910221
  36. Powles TJ, Easty GC, Easty DM, Neville AM. Anti-metastatic effect of aspirin. Lancet. 1973;2:100. · doi:10.1016/s0140-6736(73)93300-x
  37. Prescott LF. Paracetamol (Acetaminiphen). A Critical Bibliographic Review. Revised 2nd Edn. London: Taylor & Francis, 2001.
  38. Rainsford KD. History and development of ibuprofen. In: Ibuprofen. A Critical Bibliographic Review, K.D. Rainsford, ed. London: Taylor & Francis, 1999a, 1–24. · doi:10.4324/9780203362587
  39. Rainsford KD. Pharmacology and Biochemistry of salicylates and related drugs. In: Aspirin and Related Drugs, K.D.Rainsford, ed. London and New York: Taylor & Francis, 2004c,215–366. · DOI
  40. Rainsford KD. Aspirin and NSAIDs in the prevention of cancer, Alzheimer’s disease and othe novel therapeutic actions. In: Aspirin and Related Drugs, K.D. Rainsford, ed. London and NewYork: Taylor & Francis, 2004d, 707–756. · DOI
  41. Rainsford KD. Inhibitors of eicosanoids. In: The Eicosanoids, P Curtis-Prior, ed. Chichester: John Wiley &Sons, 2004e, 189–210. · doi:10.1002/0470020628.ch16
  42. Rainsford KD. Occurrence, properties and synthetic developments ofthe salicylates. In: Aspirin and Related Drugs, K.D.Rainsford, ed. London & New York: Taylor & Francis, 2004f,45–95. · DOI
  43. Rainsford KD. Aspirin and NSAIDs in the prevention of cancer, Alzheimer’s disease and other novel therapeutic actions. In: Aspirin and Related Drugs, K.D. Rainsford, ed. London & NewYork: Taylor & Francis, 2004g, 707–756. · DOI
  44. Russo-Marie F. Antiinflammatory steroids. In: The Eicosanoids. P. Curtis-Prior, ed. Chichester: John Wiley &Sons, 2004, 327–332. · doi:10.1002/0470020628.ch28
  45. Sandler M, Karim SM, Williams ED. Prostaglandins in amine-peptide-secreting tumours. Lancet. 1968;2:1053–1054. · doi:10.1016/s0140-6736(68)91528-6
  46. Skinner R. Role of topical therapies in the management of cutaneous disease. J Cutan Med Surg. 2004;8 Suppl 3:22–31. · doi:10.1007/s10227-004-0805-1
  47. Trummlitz G, van Ryn J. Designing selective COX-2 inhibitors: molecular modeling approaches. Curr Opin Drug Discov Devel. 2002;5:550–561.
  48. Van Wijk R, Wicks WD, Clay, K. Effects of derivatives of cyclic 3′,5′ -adenosine monophosphate on the growth, morphology, and gene expression of hepatoma cells in culture. Cancer Res. 1972;32: 1905–1911.
  49. Webert KE, Kelton JG. Acetylsalicylic acid for prevention and treatment of thromboembolic diseases. In: Aspirin and Related Drugs, K.D. Rainsford, ed. London & New York: Taylor &Francis, 619–633.
  50. Whittle BJ. Nitric oxide and the gut injury induced by non-steroidal anti-inflammatory drugs. Inflammopharmacology. 2003;11:415–422. · doi:10.1163/156856003322699582
  51. Wood S Jr, Hilgard P. Aspirin and tumour metastasis. Lancet. 1972;2:1416–1417.

Cited by

See all 463

Metadata

Authors
Rainsford, K. D.
Venue
Subcellular Biochemistry
Published
2007
Volume
42
Pages
3-27
ISSN
0306-0225 (ISSN-L)
OpenAlex
W129031804
Cited by
463
References
95
FWCI
76.93
Type
book chapter
Language
en
Open access
closed
Licence
www.springer.com/tdm (tdm)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Anti-Inflammatory Drugs in the 21st Century. https://app.cochat.ai/papers/10.1007/1-4020-5688-5_1
The paper
Rainsford, K. D. (2007). Anti-Inflammatory Drugs in the 21st Century. Subcellular Biochemistry. https://doi.org/10.1007/1-4020-5688-5_1

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.